Literature DB >> 15273444

Benign B-cell precursors (hematogones) are the predominant lymphoid population in the bone marrow of preterm infants.

Lisa M Rimsza1, Vonda K Douglas, Patrick Tighe, Matthew A Saxonhouse, Darlene A Calhoun, Robert D Christensen, Martha C Sola.   

Abstract

Bone marrow (BM) findings in 3rd-trimester stillborns and full-term living neonates have been previously described. However, there is no information regarding BM composition in living preterm infants. Specifically, it is unknown whether the BM lymphocytosis seen in full-term infants at 1-4 weeks of age also occurs in preterm infants. Furthermore, the lineage of these cells has never been investigated. We used a panel of immunohistochemical stains to characterize the BM composition in 11 neonates (8 living and 3 deceased). Unlike in the other age groups, immature B cells (hematogones) were the most common lymphoid population, accounting for 10-60% (mean 34%) of all cells. In two additional cases (both living patients), flow cytometry revealed a level of 3.8% of immature B cells in a <1-week-old neonate and 25.7% in a 19-week-old infant. Immature B cells were not identified in 6 peripheral blood samples from preterm neonates. These findings are pertinent for the interpretation of BM and peripheral blood samples in this age group as survival improves and diagnostic samples become more common. 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273444     DOI: 10.1159/000079907

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

Review 1.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

2.  The presence of precursors of benign pre-B lymphoblasts (hematogones) in the bone marrow of a paediatric patient with cytomegalovirus infection.

Authors:  F Moreno-Madrid; J Uberos; M Díaz-Molina; A Ramírez-Arredondo; P Jiménez-Gámiz; A Molina-Carballo
Journal:  Clin Med Oncol       Date:  2008-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.